Cite
HARVARD Citation
Stehn, J. et al. (n.d.). Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC). European journal of cancer. pp. S116-. [Online].